Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $297.4 million.

  • National Healthcare's Cash & Current Investments rose 1916.24% to $297.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $297.4 million, marking a year-over-year increase of 1916.24%. This contributed to the annual value of $216.2 million for FY2024, which is 92.03% down from last year.
  • Per National Healthcare's latest filing, its Cash & Current Investments stood at $297.4 million for Q3 2025, which was up 1916.24% from $257.6 million recorded in Q2 2025.
  • National Healthcare's Cash & Current Investments' 5-year high stood at $297.4 million during Q3 2025, with a 5-year trough of $147.0 million in Q1 2023.
  • Moreover, its 5-year median value for Cash & Current Investments was $218.2 million (2023), whereas its average is $218.6 million.
  • Per our database at Business Quant, National Healthcare's Cash & Current Investments surged by 6672.73% in 2021 and then crashed by 3501.43% in 2022.
  • Quarter analysis of 5 years shows National Healthcare's Cash & Current Investments stood at $220.7 million in 2021, then decreased by 27.76% to $159.5 million in 2022, then soared by 36.84% to $218.2 million in 2023, then decreased by 0.92% to $216.2 million in 2024, then soared by 37.56% to $297.4 million in 2025.
  • Its last three reported values are $297.4 million in Q3 2025, $257.6 million for Q2 2025, and $243.2 million during Q1 2025.